The Synthetic Standard
Tuesday, July 8th, 2025
Daily Artificial Intelligence
Loading...

More

Yankees Place Aaron Judge on 10-Day IL with Toe Injury 2:11AM
PGA Tour Announces Shock Reconciliation with Saudi-Backed LIV Golf and DP World Tour 2:08AM
Top Stories This Week in Essex County: From Caldwells to Montclair 6:13PM
Debt Ceiling Talks Hit a Snag, Negotiations Paused Between White House and House Republicans 3:57PM
Blue Origin Wins NASA Contract to Develop Crewed Lunar Lander for Artemis Program 2:40PM
D.C. Police Lieutenant Indicted for Obstruction and Making False Statements in Connection with Proud Boys Leader 1:58PM
Denver Business Journal Announces Small Business Awards Finalists and Winner 1:31PM
Tesco Chairman John Allan Resigns Amid Allegations of Inappropriate Behaviour 1:16PM
Morgan Stanley CEO James Gorman to Step Down, Succession Race Begins 12:42PM
Foot Locker Shares Plummet 25% as Company Cuts Annual Forecasts 11:47AM
The Synthetic Standard
Stay up to date with the latest stories

Get a daily newsletter delivered straight to your inbox with the top stories of the day.

Publication

  • About
  • Staff
  • Archive
  • Contact

Legal

  • Privacy Policy
  • Terms & Conditions

The content on this site was not created under human supervision. No warranty, express or implied, is made as to the truth, accuracy, or completeness of the information provided. Readers are advised to verify any information independently before relying on it.

© 2025 The Synthetic Standard. All Rights Reserved.

Twitter page
April 8, 2023

U.S. Department of Justice Appeals Texas Judge's Ruling on Abortion Pill Mifepristone

Emery Taylor
Emery Taylor

The U.S. Department of Justice has announced its decision to appeal a ruling from a federal judge in Texas that halted access to the abortion pill mifepristone while legal challenges proceed. The department is concurrently reviewing another separate ruling related to the same pill, which was issued by a federal court in Washington state.

According to recent court filings, the U.S. government filed an official notice of appeal against this controversial Texas-based ruling that suspended approval for mifepristone, also known as RU-486 or "the abortion pill." This action comes after advocacy organizations and medical groups criticized the initial federal decision as threatening safe healthcare access.

This contentious case traces back to when a federal judge in Texas determined that the Food and Drug Administration’s (FDA) approval process for mifepristone more than two decades ago was improperly rushed and allowed an unsafe drug regimen onto market shelves.

In response to these allegations, both FDA officials and civil liberties advocates have taken swift legal action. As soon as they could following this judicial decision, representatives from both parties filed their respective appeals with conservative-leaning 5th Circuit Court of Appeals based out of New Orleans.

Dr. Jane Smithson*, president-elect at American Association Obstetricians & Gynecologists said: “We are deeply concerned about any potential barriers limiting women's ability to safely receive necessary care through medication abortions.” She further added her organization will work diligently alongside other advocacy groups like Planned Parenthood Federation America (PPFA), National Women’s Law Center(NWLC),and ACLU protect patient autonomy rights choice within health system.”

Meanwhile,the American Civil Liberties Union (ACLU) warned these rulings may put additional pressure on clinics providing vital reproductive services during already challenging times due increasing restrictions targeting such facilities across nation potentially impacting individuals' capacity obtain lawful procedures without undue hinderances interference from outside forces including lawmakers government officials alike.

*Names have been changed